Benzodiazepines Flashcards

1
Q

Meprobamate (MPB)

A

MPB was an early non-barbiturate anxiolytic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

MPB potentiates GABAA and acts as

A

a weak
partial agonist at the GABA site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Meprobamate (MPB) Eventually withdrawn due to

A

abuse potential and
narrow safety margin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Chlordiazepoxide found to have

A

sedative,
anxiolytic, and anticonvulsant effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

(Valium)

A

diazepam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

BZD Effects

A

Anxiolytic and anticonvulsant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

BZD Effects - sedation

A

less potent than barbiturates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

BZD & muscles

A

Muscle relaxant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

BZD Not effective as _____ but

A

anaesthetics BUT can be used as relaxants for pre-surgical anaesthesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Midazolam

A

is a short-acting BZD used for brief
surgical procedures with local anaesthetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Midazolam recovery

A

Recovery in a few hours with anterograde
amnesia – creates the illusion of anaesthesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

BZD Effects Lower incidence of (3)

A

tolerance,
less severe withdrawal,
greater safety margin than barbiturates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

BZD use - like

A

Like barbiturates, the effects of BZDs vary with their rate of onset and duration of effect in the body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

BZDs have more rapid

A

onset and
termination of effect with increased
lipophilicity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

BZDs often have active

A

e metabolites
generated by type I metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

BZD Pharmacology

A

Some of the effects of BZDs relate to their slow metabolism and number of active metabolites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

duration of effect of Benzos list

A

Oxazepam < Diazepam < Flurazepam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Diazepam half life

A

1-3 days but metabolites can be active and go on to have effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Nordazepam results from _____ and has a half life of

A

Demethylation of Diazepam - half life of 2-7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Oxazepam results from _____ and has a half life of

A

oxidation and Demethylation of diazepam - half life of 4-15 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

temazepam results from _____ and has a half life of

A

oxidation of diazepam - half life of 4-18 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

prolonged action of metabolites

A

is beneficial for
anxiolytic and anticonvulsant use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Long elimination of metabolites reduces

A

reduces the
withdrawal syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

BZD metabolism - Short-acting BZDs

A

Enter the brain quickly due to high lipophilicity
Terminate quickly due to depot binding in fatty
tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
BZD metabolism - Short-acting BZDs
- Enter the brain quickly due to high lipophilicity - Terminate quickly due to depot binding in fatty tissues - Tend to have ‘hangover’ effects due to slow release from fatty tissues
26
BZD metabolism - Long-acting BZDs
* Slower onset due to lower lipophilicity * Not readily taken up into fatty tissues * Multiple active metabolites * Long elimination half-lives * Reduced withdrawal effects due to slow decline in systemic levels
27
BZD receptor - BZD are
positive allosteric modulators at the GABAA receptor
28
BZD site of GABAA is often referred to as
the BZD receptor
29
Many types of interactions at the BZD receptor
* Agonists (+ allosteric modulator of GABAA) * Partial agonists * Antagonists * Inverse agonists (- allosteric modulator of GABAA)
30
Classic benzodiazepines act as
positive allosteric modulators of GABA-A
31
BZD binding increases the
response of the channel to lower concentrations of GABA
32
BZD increase the frequency of
channel opening
33
Unlike barbiturates BZDs do not
have GABA mimetic activity
34
The BZD site has for many years been considered an ‘orphan receptor’
The existence of a natural ligand for the BZD site is proposed
35
Several compounds have been identified that bind the BZD site - termed
‘endozepines’
36
β-carbolines
Small molecule inverse agonists at the BZD site
37
β-carbolines list
* β-CCE * β-CCM * DMCM
38
Diazepam-binding inhibitor (DBI)
Protein inverse agonist at the BZD site
39
The BZD site of GABAA is able to elicit both
h positive and negative allosteric modulation of GABA activity.
40
Negative allosteric modulators exert
biological effects as inverse agonists of the BZD site
41
Inverse agonists bind and exert - biological effect
biological effect that is opposite that of agonists.
42
Effects of BZD classes - Typical agonists: Classical BZD anxiolytics
Diazepam, lorazepam, flunitrazepam
43
Typical agonists: Exert
positive allosteric modulation on GABAA
44
Typical agonists: effects
Anxiolytic, sedative-hypnotic, anti-convulsant
45
Competitive antagonists exert
Exert no effect at the BZD site but displace agonist binding
46
Competitive antagonists: Flumazenil
used to treat BZD overdose
47
Inverse agonists
Negative allosteric modulators of GABAA
48
Inverse agonists - effects
Anxiogenic
49
Inverse agonists - Principally experimental compounds, no
therapeutic benefit
50
To date most proposed endozepines function as
inverse agonists at the BZD site
51
Endozepines are
anxiogenic
52
In animal studies endozepines increase (3)
agitation, increase distress vocalizations, and increase aggressive behaviours
53
In human volunteers, endozepine administration increased (3)
muscle tension, autonomic hyperactivity, extreme apprehension
54
The function of endozepines supports the model that the
BZD receptor site plays a natural role in anxiogenesis
55
BZD drugs may in fact
antagonize endozepine-induced anxiety
56
BZD tolerance and dependence - tolerance
No metabolic tolerance develops (no enzyme induction)
57
Rapid tolerance develops to
muscle relaxant and sedative effects (pharmacodynamic)
58
Very little tolerance develops to
anxiolytic effects
59
Many adverse side effects of BZDs when used because
anxiolytics are transient and dissipate as the tolerance develops to the sedative effects
60
Animal models of dependence show BZDs to have
low risk of dependence
61
* Dependence seems to be problematic in
n human clinical use and abuse
62
Convergent site of action with
barbiturates and alcohol
63
Convergent site of action with barbiturates and alcohol
Cross-tolerance and potential for drug interactions
64
BZDs interact with alcohol and pose
e increased risk of toxicity and abuse when co-administered
65
, BZDs are effective at treating
alcohol withdrawal in chronic alcoholics
66
BZDs have increased risk of adverse events in
elderly patients due to decreased liver function
67
BZDs tend to _____ in elderly patients causing adverse events
bioaccumulate
68
Rebound effects
Rebound insomnia Anxiety
69
Withdrawal effects: (4)
* Fearfulness * Tremors * Agitation * Muscle spasms
70
Withdrawal easily managed with a
a long-acting BZD such as diazepam and slow weaning off the drug
71
Adverse intoxication can occur
at higher doses
72
Adverse intoxication can occur at higher doses (4)
* Disorientation * Cognitive impairments * Amnesia * Sedation
73
Paradoxical effects at high doses
* Aggression * Irritability * Anxiety
74
* Overdose can be managed by
BZD competitive antagonist
75
BZD competitive antagonist
Flumazenil displaces BZDs but has a short half-life
76
Overdose can present with
unconsciousness but respiratory depression is only seen when another drug is present
77
Overdose can present with unconsciousness but respiratory depression is only seen when another drug is present
Common with alcohol
78
Triazolam is a
short-acting BZD with rapid clearance used to treat insomnia (less hangover sedating effects)
79
Triazolam causes people
to do violent things